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Abstract Composite tissue transplantation and new
developments in the field of prosthetics have opened new
frontiers in the restoration of function among upper limb
amputees. It is now possible to restore hand function in
affected patients; however, the indications, advantages, and
limitations for either hand transplantation or prosthetic
fitting must be carefully considered depending on the level
and extent of the limb loss. Hand transplantation allows
comprehensive hand function to be restored, yet composite
tissue transplantation comes with disadvantages, making
this method a controversial topic in the hand surgical
community. Alternatively, prosthetic limb replacement
represents the standard of care for upper limb amputees,
but results in the known limitations of function, sensation,
and usage. The indication for hand transplantation or
prosthetic fitting strongly depends on the level of ampu-
tation, as well as on the extent (unilateral/bilateral) of the
amputation. In this review, we discuss the advantages and
disadvantages of hand transplantation and prosthetic
replacement for upper limb amputees in general, as well as
in regard to the different levels of amputation.
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Introduction
Young people are particularly at risk of upper limb
amputations, as trauma is the leading cause [1, 2]. This is in
contrast to lower limb amputees, which mainly occur in
elderly patients with end-stage vascular diseases or dia-
betes [3]. Hands are needed for almost every activity of
daily life. In addition, hands are an essential part of our
appearance, are important for our physical and psycho-
logical development, and play a significant role in deter-
mining our professional career [4–6]. These facts highlight
the importance and necessity of reliable replacement of
upper limb function. Attempts to replace this highly
sophisticated organ have been developed over the past
70 years in both the fields of surgery and prosthetic
reconstruction [7••, 8].
Composite tissue transplantation and improvements in
the field of prosthetics have opened new frontiers in
restoring hand function. The first documented hand trans-
plantation was performed in Ecuador in 1964 [9]. Due to
insufficient immunosuppressive treatment, the hand had to
be removed 2 weeks later [10]. A group in France then
performed the first successful human hand transplant in
1998 [11]. Since then, 107 upper extremity transplantations
in 72 patients have been performed in 26 centers world-
wide [12••].
Historically, the first electronically-driven hand pros-
theses were developed towards the end of World War Two
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[13]. Cosmetic features, weight savings, battery life, and
components have improved over time, and prosthetic fit-
tings with myoelectric devices have been established as the
standard of care in upper limb amputees [14]. These
myoelectric systems are controlled by a minimum of two
individual muscle groups at the remnant limb of the
amputee [13]. Prosthetic fitting can take place soon after
the initial injury with short hospitalization and rehabilita-
tion [2].
Hand transplantation and prosthetic fitting both have
their advantages and limitations. Unlike solid organ
transplantation, limb transplantation involves the risk of a
shortened life expectancy but may improve its quality.
Therefore, the risk–benefit ratio becomes far more delicate,
subjective, and hence controversial. In this review, we will
discuss the advantages and disadvantages of hand trans-
plantation and prosthetics for upper limb amputees in




Hand transplantation perfectly fulfills Sir Harold Gillies’
concept of ‘‘replacing like with like,’’ while avoiding donor-
site morbidity [10]. Successful hand transplantation replaces
the lost body part with a limb that is silent, worn constantly,
never exhausted, aesthetically pleasing, warm to touch and
hold, and with the self-repairing qualities of the biologic
tissue. Hand transplantation does not only restore motor
function but also enables a sense of touch, bodily integrity,
ownership, and wholesomeness [15]. Although functional
outcomes are not reported as consistently, different groups
show excellent and long-lasting results [16•, 17].
Apart from long-lasting rehabilitation and recurrent
inpatient treatment, the need for immunosuppression is the
greatest risk of composite tissue transplantation. The pos-
sible side effects of immunosuppressive drugs are well
known and not to be ignored, with every patient experi-
encing at least one acute episode of rejection [18, 19]. The
number of such episodes may be important, as rejection has
a negative influence on sensory and motor recovery [20].
Although some authors state that selected patients for
transplantation are otherwise healthy and most probably do
not have comorbidities that impact on the side effects [10,
21, 22], considering all possible complications, lifelong
immunosuppression is not to be underestimated. As
chronic hypertension increases the risks of vascular
infarction, long-lasting immunosuppression increases the
risk of infection, neoplasia, metabolic disorders or organ
failure [23, 24]. Furthermore, the need for immunosup-
pression requires the taking of a considerable amount of
drugs according to a strict time schedule. Blood samples
need to be taken frequently to monitor side effects such as
nephrotoxicity, and other investigations are necessary for
follow-up. Despite strict transplant care, the risk of acute
rejection remains high [10]. Thus, in the latest review of
the worldwide experience with hand transplantation, 24
graft losses were reported (22.4 % loss rate for all limbs)
due to patient death, acute or chronic limb loss [12••].
As can be seen in the first case from France, non-com-
pliance with immunosuppression and physical rehabilita-
tion leads to poor functional outcome. In that case, Merle
described hand function as ‘‘effectively a paperweight.’’
[25] Considering the re-amputation of the French patient,
Cooney et al. asked a decisive question: ‘‘How good is the
achievable ‘quality of life’ with a new limb when daily
medications are required to maintain its viability?’’ [26]
However, if patient selection and postoperative treatment
are adequate, hand transplantation can achieve excellent
hand function and a tremendous improvement in the
patient’s quality of life.
Hand Prosthetics: Advantages and Limitations
Prosthetic replacement in upper limb amputees has for
many years been considered as the standard of care [13,
14]. Yet, prosthesis use is notoriously challenging for
activities like carrying out body hygiene or grooming.
Therefore, different prosthetic attachments can be custom-
fitted for different tasks in daily life. However, the aban-
donment of expensive prosthetic devices represents an
economic problem and a burden for all different profes-
sions involved in the prosthetic fitting of upper limb
amputees. A literature review from 2007 observed an
average rejection rate of all prostheses (cosmetic, body-
powered, myoelectric) in 1 out of 5 individuals with upper
limb deficiency over the last 25 years [27].
A myoelectric prosthesis is able to replace sufficient
motor function to aid in daily life activities; however, the
lack of sensory information leads to difficulties in per-
forming precise motor commands as visual control is
mandatory [7••]. The missing sensory feedback represents a
major burden especially in bilateral amputees.
However, prosthetic fitting can take place early after the
injury, and controlling the prosthesis especially for below-
elbow amputees is mostly intuitive and easy to learn in an
adequate rehabilitation setting. Furthermore, no additional
surgery or life-long medication is needed to fit an upper
limb amputee with a prosthetic device, and patients can
return to near normal life reasonably quickly [14].
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Indications
In composite tissue transplantation, which represents a
surgically and immunologically invasive procedure with
the necessity of life-long medication, patient selection is
crucial. According to the principle of Primum non nocere,
a surgical intervention is indicated if the patient’s life time
can be prolonged, their condition be improved and addi-
tional risks are acceptable and outweighed [28]. Following
the first successful transplantations, this procedure was
considered as a new avenue in upper extremity recon-
struction; nevertheless, not all hand surgeons supported the
concept of reconstructive transplantation [6]. A survey by
Mathes et al. revealed that bilateral below-elbow amputa-
tion was the most accepted indication for hand transplan-
tation by hand surgeons of the American society (78 %),
whereas only 32 % also supported hand transplantation in
patients after unilateral amputation of the dominant hand
[29]. A majority (69 %) of the respondents in this survey
assessed hand transplantation as a high-risk endeavor, and
were either against hand transplantation (45 %) or unde-
cided (31 %) [29]. However, this survey is from 2009 and
attitudes towards hand transplantation might have changed.
After amputation of the dominant hand, the healthy non-
dominant hand will most probably become dominant [10].
Even in bilateral transplant patients, changes of the domi-
nant hand and dexterity after transplantation have been
reported [30]. In unilateral amputees, the reconstructed
hand, either a transplanted or a prosthetic one, will be a
helping hand [31]. Probably more important than dominant
or non-dominant is the fact that patients who lose their
right hand feel uneasy and intimidated because they cannot
shake hands in an ordinary manner. In unilateral trans-
plantations, the difference between both hands in size, skin
texture and color or hair growth will always be noticeable
[31], although the aesthetic appearance with transplantation
will always be superior to a prosthetic hand. Nevertheless,
individuals’ views of risk can differ greatly. A survey of
amputee patients, organ transplant recipients and healthy
subjects showed that hand/arm amputees did not see a great
benefit in a single hand transplant [32]. The amputee
patients were significantly less willing to accept the risks of
a single hand transplant than the group of organ transplant
recipients and also less willing to accept a single hand
transplant compared to the healthy volunteers [32]. The
risk acceptance for a bilateral hand transplantation was
nearly twice as high as for unilateral transplantation, and
the organ-transplanted group were willing to accept nearly
the same amount of risk for bilateral hand or kidney
transplantation [32]. These results suggest that amputee
patients are coping effectively with one functioning hand
and their prostheses, and therefore the risk acceptance in
regard to immunosuppression is low. However, in unilat-
eral amputees, psychological impairment is claimed as one
of the major indications for hand transplantation [18, 33].
Additionally, a sensate stump in distal unilateral amputees
is quite functional, and these patients can usually perform
up to 90 % of the activities of daily living together with the
sound arm [34, 35].
According to the latest report of the International Reg-
istry on Hand and Composite Tissue allotransplantation
from 2011, 44 % of the transplanted patients were per-
formed on bilateral amputees [19]. However, in a recent
review covering the worldwide experience of upper
extremity transplantation from Shores et al., all known
cases were summarized, showing a paradigm shift within
the last years [12••]. As can be seen in Fig. 1, unilateral
hand transplantations were more common in the initial
years, before bilateral transplantation became the main
indication from 2008 onwards.
One of the major causes of upper limb amputations are
explosion or burn injuries, also leading to visual impair-
ments or blindness in some patients [36]. Performing hand
transplantation in a blind amputee may provide him with
both motor and sensory function, which cannot be offered
by the current generation of prosthetic devices [37]. Nev-
ertheless, the sensory feedback of a transplanted hand will
not be comparable to the sensory capacity of the sound skin
at the stump region. Therefore, hand transplantation in
blind upper limb amputees is controversial [36–38].
Replantations have shown that the functional outcome is
also dependent on the level of amputation: the higher the
amputation, the less successful the outcome [39]. Thus,
transplantations have been favored at the distal transradial
or even wrist level [38]. The ideal patient for hand trans-
plantation would be a bilateral distal transradial amputee
suffering a sharp traumatic injury who is already under
immunosuppression because of a life-saving procedure
[40].
Fig. 1 Relationship between unilateral and bilateral cases from the
total number of hand transplantations performed
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The motives driving patients to have hand transplanta-
tion are distinct. In general, unilateral amputees primarily
report difficulties with coping and psychological issues,
whereas patients with bilateral amputation especially suffer
from functional impairment and loss of quality of life [18].
However, an overwhelming majority (71 %) of surgeons in
the survey of Mathes et al. believe that hand transplantation
does produce a benefit when performed on a properly
selected patient [29]. Although requested by experts of this
field, surprisingly, a comparison of hand function of
transplanted hands with up-to-date prosthetic hands at a
similar amputation level has not yet been performed [41].
The largest trial comparing hand function of prosthesis and
replants was performed by Graham et al. [42]. Neverthe-
less, they include different amputation levels and different
prosthetic devices.
Rehabilitation
As Ninkovic et al. states, the clinical outcome after hand
transplantation is strongly dependent on genetic matching,
number of rejection episodes and the chosen immunosup-
pressive regimen, precise and accurate surgery and to a
great extent on adequate rehabilitation [17]. The expense
for rehabilitation in hand transplantation is tremendous. It
needs a carefully selected patient who is willing to take the
burden of several months of inpatient treatment and a life-
long engagement for his hand. A single-center cohort of
patients received an average inpatient treatment for
4.25 ± 5.02 months with 3-4 h of therapy for 7 days a
week, and later an average outpatient treatment of
11.16 ± 9.31 months with 3–6 h for 5 days a week [17].
Prosthetic fitting can be performed as early as 3 months
post-amputation, after swelling of the stump has resolved
and atrophy of the muscles is stable. This delivers a con-
stant and to a great extent predictable outcome which can
be further improved over time [14]. Prosthetic rehabilita-
tion usually starts a few weeks after surgery and at best
even before prosthetic fitting [43]. Since standard pros-
theses are controlled by two independent (mostly antago-
nistic) myoelectric signals, the voluntary contraction of the
corresponding muscles is trained in therapy. Using elec-
tromyography (EMG) biofeedback devices, this can also be
done without a prosthesis. Amputees usually learn how to
control the two myoelectric signals within a few therapy
sessions. As soon as the prosthesis is fitted, the focus is on
using it in activities of daily living (Fig. 2). Different
strategies on how to perform certain tasks are discussed
and tested in therapy. This should enable the patient to use
the prosthesis in a way that supports him/her in daily life.
To our knowledge, there is no precise recommendation for
the amount of therapy needed for a standard fitting.
Nevertheless, in our experience, 10–20 h of therapy in total
are usually enough. Only in cases with additional surgery
to improve the man–machine interface (e.g., nerve or
muscle transfers) may the rehabilitation time be prolonged
[14, 44, 45].
Costs
The costs of the reconstructive procedure play an important
role for the public and private insurance providers. Other
organ transplantations, such as liver and heart, which are
even more expensive, are widely accepted because of the
lack of alternatives in the treatment of life-threatening
conditions. As stated earlier, hand or arm amputation is not
a life-threatening condition and prosthetic devices do pro-
vide a reliable and less expensive alternative. Different
financial factors have to be taken into account, including
surgical costs, in- and outpatient treatment, occupational
therapy, immunosuppressive drugs and the time out of
employment [46]. Cost–utility analyses have been per-
formed and have concluded that prosthetic fitting would be
the preferred treatment for upper extremity amputees, both
in uni- and bilateral cases [47]. Recently, the Swiss Health
Care Association rejected hand transplantation as a treat-
ment modality because of the fourfold costs of composite
tissue transplantation compared to prosthetic fitting [48].
Level-By-Level Analysis
Below the Elbow
Below the elbow, including proximal and distal transradial
amputations as well as the wrist level, represents the level
of amputation with the best possible outcome either with
prosthetic devices or hand transplantation [14, 17]. Thus,
hand transplantation at the transradial or wrist level is the
most common composite tissue transplantation [19].
Fig. 2 A prosthesis used in activities of daily living
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However, the functional outcome of the hand in daily life is
strongly dependent on the shoulder and elbow function of
the patient. A good shoulder and elbow joint is essential to
move the hand (transplanted or prosthetic device) in three-
dimensional space.
In hand transplantation below the elbow, the patient’s
own self-innervated extrinsic flexors and extensors are
moving the transplant, and in some cases intrinsic muscle
function will be regained after successful nerve regenera-
tion. However, some hand function is present from the first
day after surgery and therefore not dependent on the suc-
cess of nerve regeneration.
Myoelectric prostheses for below-elbow amputees are
controlled by two individual muscle groups of the
remaining limb, using signals from one muscle group to
open and another to close the hand, with some advanced
devices allowing movements of the wrist or specific grip
patterns [13]. Thus, controlling the prosthesis for a below-
elbow amputee is mostly intuitive and easy to learn in an
adequate rehabilitation setting.
Above the Elbow
Above-elbow transplants are less frequent compared to the
below-elbow amputation level, with six known transplan-
tations worldwide [12••]. The distances for nerve regenera-
tion and the number of muscles that need to be reinnervated
are the major concerns in limb transplantation at the tran-
shumeral level. As not only the intrinsics but also all finger/
wrist flexor and extensor muscles are not working during the
months of nerve regeneration, the course of rehabilitation is
even longer and results in further obstacles for motor
recovery [49]. Due to the distance from nerve coaptation to
the distal hand, no recovery of the intrinsic muscles has been
reported [50]. As Shores et al. state, the best to be expected is
some forearm pronation/supination, wrist flexion/extension
and enough extrinsic digit flexion/extension for the hand to
function as a helping hand only [50].
Conventional myoelectric upper arm prostheses are
controlled by surface electrodes that are sourced by two
separately innervated muscle groups [14]. Since the pros-
theses usually have an elbow, wrist and hand joint,
switching between these levels is necessary. This is
achieved via co-contraction. Therefore, conventional con-
trol of above elbow prostheses is slow and unintuitive [14,
51]. To enhance prosthetic control at this amputation level,
a new surgical option has been established over the last
15 years [52]. The multiplication of EMG sites with
selective nerve transfers of the brachial plexus to the
remaining stump muscles, known as the targeted muscle
reinnervation (TMR) technique, has enabled prosthetic
control in a way that was harmonious with the natural
pattern of movement without the need to change between
the different prosthetic joints [53]. The functional benefit of
TMR in high-level amputees compared to conventional
myoelectric or body-powered prostheses has been shown
by various groups [14, 51–54].
Shoulder
Limb transplantation is currently not proposed at this level
of amputation, as the distance for nerve regeneration would
be even longer than at the above-elbow level, as well as
requiring an additional joint to be transplanted and with
elbow function also dependent on nerve regeneration,
compared to the above-elbow level [55]. Furthermore,
skeletal attachment would be challenging.
This level of amputation represents a standard indication
for TMR surgery, although prosthetic replacement with a
functional myoelectric shoulder joint is only possible in the
laboratory setting at this time [14]. These patients are fitted
with a passive shoulder joint, and a myoelectric elbow, wrist
and hand. Theprinciple of theTMRsurgery remains the same,
with only the targetedmuscles for nerve transfers changing. In
regard to neuroma pain, these nerve transfers, as well as limb
transplantation, take care of all amputation -neuromas, as they
rewire each nerve to a useful distal target [14].
Future Outlook
Hand transplantation as well as prosthetic devices will
most definitely further improve within the next years. The
successful induction of donor-specific tolerance would
have great impact on the range of indication, as the risk of
chronic rejection could be reduced or even eliminated,
resulting in a safe transfer and most probably improved
motor and sensory outcomes [31, 56]. On the other hand,
new control algorithms such as pattern recognition will
enhance the functionality and applicability of prosthetic
devices. Recently, such an algorithm has become com-
mercially available (Coapt) with future improvements on
the horizon, and broad uptake can be expected in the near
future [13, 27]. Ongoing research is focusing on providing
the prosthesis user with tactile and proprioceptive feed-
back; however, to date, these systems are not available for
clinical use [57]. Thus, future developments of prosthetic
devices will have great impact on the indications for
composite tissue transplantation [28].
Conclusion
Hand transplantation poses a sophisticated opportunity to
truly restore hand function in combination with sensation
and self-perception, and therefore enhancing the quality of
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life in upper limb amputees [18]. Nevertheless, even
17 years after the first successful hand transplantation in
human and an experience of over 100 transplanted limbs
worldwide, composite tissue transplantation is still a con-
troversial topic in the hand surgery community [46].
Although limb loss is not a life-threatening condition,
losing one or even both hands leads to severe functional
impairments as well as an immense psychosocial burden
[31]. In bilateral limb loss, the benefits of motor and sen-
sory restoration may outweigh the risks of immunosup-
pression, leading to superior outcomes compared to
prosthetic fitting, especially in below-elbow amputees [58].
As unilateral amputees are able to compensate for the
majority of the functional deficit using their remaining
healthy hand and a prosthesis, the indication for hand
transplantation should be focused on bilateral below-elbow
limb loss [18, 58]. The ideal candidate would be a patient
who is already under immunosuppression for a life-
threatening condition and has lost both his hands [40]. This
patient would benefit from all the advantages of hand
transplantation without additional risks [5, 20]. Although
some patients have reported that there were tasks like
carrying heavy objects which were easier with the pros-
thesis, if hand transplantation is successful, overall func-
tional outcome is superior to any current prosthetic device
in below-elbow amputees [58, 59].
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